Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors
NCT01479023
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
12
Enrollment
OTHER
Sponsor class
Stopped
treatment was not working
Conditions
Carcinoma
Sarcoma
Lymphoma
Interventions
DRUG:
64Cu-DOTA-U3-1287
DRUG:
U3-1287 (unlabeled)
Sponsor
Washington University School of Medicine